Friday, July 10, 2026

pharma · Solid Tumors · Primary Dysmenorrhea

Topiloric/Uriadec

Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl

SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SOUTH SAN FRANCISCO, CA, JP
Employees
2
Programs
12
Drugs
7
Patents
52
Clinical program

SilMAKin

Phase 1 · other · chronic liver disease

SilMAKin for chronic liver disease is a Phase 1 program (other) at Topiloric/Uriadec with 1 ClinicalTrials.gov record(s).

Internal code SilMAKin

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Topiloric/Uriadec
Phase
Phase 1
Modality
other
Indication
chronic liver disease
Status
active
Trials
1

Clinical trials